Breo Asthma NDA Remains Up In The Air
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
GlaxoSmithKline and partner Theravance continue to mull the possibility of an asthma NDA for the combination of fluticasone furoate and vilanterol.